Conjugated Estrogens
- 网络结合雌激素;共轭雌激素;结合型雌激素;妊马雌酮;倍美力片
-
Study on animal pharmacodynamics of compound conjugated estrogens tablets
复方结合雌激素片的动物药效学研究
-
Studies on the HPLC / GC Fingerprints and LC-MS Qualitative Analysis for Conjugated Estrogens
结合雌激素HPLC、GC指纹图谱研究及LC-MS定性分析
-
The effect of conjugated estrogens soft vaginal capsules on uterus weight of mice was observed .
小鼠阴道给药后考察结合雌激素软胶囊内容物对未成年雌性小鼠子宫指数的影响。
-
Conclusion : The compound conjugated estrogens tablets possess the estrogenic and progestational activities .
结论:复方结合雌激素片具有明显的雌激素活性及一定的孕激素活性。
-
Objectives : To establish the HPLC and GC fingerprints of conjugated estrogens ( CE ) material for the quality control of conjugated estrogens material ;
目的:建立结合雌激素原料药的HPLC和GC指纹图谱,评价结合雌激素原料药的内在质量;
-
AIM : To investigate conjugated estrogens medroxyprogesterone acetate ( Pre ) in prevention and treatment of blood lipid disorder and cardiovascular disease for postmenopause women .
目的:探讨结合雌激素醋酸甲羟孕酮(Pre)替代防治绝经后妇女的血脂紊乱及心血管疾病。
-
Conclusions The low dose Conjugated Estrogens and livial can relieve climacteric symptoms safely on women who have had endometriosis and underwent hysterectomy and bilateral salpingo-oophorectomy .
结论小剂量倍美力和利维爱用于Ⅲ-Ⅳ期子宫内膜异位症切除术后患者,均能安全,有效地控制围绝经期症状。
-
Identification of medroxyprogesterone acetate tablets by infrared spectrophotometry Methods : 1 ) To develop a HPLC method for the determination of medroxyprogesterone acetate ( MPA ) and conjugated estrogens ( CE ) .
方法:1)建立复方结合雌激素片剂中安宫黄体酮(又名:醋酸甲羟孕酮Medroxyprogesteroneacetate,MPA)和结合雌激素(ConjugatedEstrogens,CE)的含量测定方法一高效液相色谱法。
-
Methods 52 women with hypercholesteremia after menopause was treated with 0.625 mg / d Premarin ( conjugated estrogens ) and 4 mg / d medroxyprogesterone acetate ( MPA ) .
方法选取符合条件的绝经后高胆固醇血症妇女52例,给予妊马雌酮0.625mg/d,安宫黄体酮(MPA)4mg/d治疗。
-
Lower dosages of conjugated equine estrogens in hormone replacement therapy
低剂量共轭雌激素的激素替代疗法
-
Premarin , purified from pregnant horse , is one of the most common use conjugated equine estrogens in previous researches .
倍美力(孕马血清中提纯的一种动物源性雌激素)是临床上最常用的激素替代药物,以往有关ERT的临床和实验室用药大多采用以倍美力为代表的结合性雌激素。